Montreal, Canada

Wilson H Miller

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Samuel Waxman Cancer Research Foundation. Active years: 2014.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wilson H. Miller: Innovator in Cancer Treatment

Introduction

Wilson H. Miller is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on enhancing the efficacy of existing treatments, particularly through the use of unique compositions.

Latest Patents

Wilson H. Miller holds a patent for "Compositions and methods for cancer treatment." This invention relates to compositions that comprise a vitamin E analog and an arsenic compound aimed at treating hyperproliferative cell disorders such as cancer. The composition is designed to potentiate arsenic toxicity towards cancer cells while preventing arsenic-mediated toxicity in non-cancerous cells. He has 1 patent to his name.

Career Highlights

Miller is associated with the Samuel Waxman Cancer Research Foundation, where he continues to advance his research in cancer therapies. His work is pivotal in developing new methods that could potentially improve patient outcomes in cancer treatment.

Collaborations

Throughout his career, Wilson H. Miller has collaborated with esteemed colleagues, including Zuanel Diaz Heredia and Hyman M. Schipper. These collaborations have enriched his research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Wilson H. Miller's innovative approach to cancer treatment exemplifies the impact of research and invention in the medical field. His contributions are vital in the ongoing fight against cancer, showcasing the importance of collaboration and innovation in developing effective therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…